We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
- Authors
Patt, Yehuda Z; Hassan, Manal M; Lozano, Richard D; Brown, Thomas D; Vauthey, J Nicolas; Curley, Steven A; Ellis, Lee M
- Abstract
Because cirrhosis is extremely common in hepatocellular carcinoma (HCC) in the United States, and it precludes the use of several chemotherapy agents, this phase II trial of fluorouracil (FU) and recombinant interferon alfa-2b (rIFNalpha2b) in HCC was launched with the assumption that it could be tolerated by cirrhotics.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Vol 21, Issue 3, p421
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2003.10.103